InvestorsHub Logo
Followers 3
Posts 190
Boards Moderated 0
Alias Born 05/16/2013

Re: None

Sunday, 06/14/2015 5:52:52 PM

Sunday, June 14, 2015 5:52:52 PM

Post# of 426271
Seems to me this 1st Amendment suit takes over where SPA appeals left off. Rather than make a final appeal to an adversarial party under their terms, Amarin is taking a different tack: Complain to the courts that its first amendment free speech rights are being abused, and provide the court with the history of the SPA debacle as part of their complaint.

I have not read the FDA "regulatory" letter response, so I'm not sure, but if the FDA has responded directly to the SPA sections of the claim, then it may well be a matter of whether the judge wishes to include language about the SPA in their ruling.

It's like Amarin is exposing a loose piece of thread and getting the courts to unravel an entire piece of regulatory cloth.

My questions: Are we even sure that legal counsel outside the FDA even reviewed their response letter before they posted it? And if so, did they even care to question the quality of the response - or did they just let it go because they couldn't care less?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News